Naresh K. Nayyar
Consigliere Generale presso TURG POIN
Posizioni attive di Naresh K. Nayyar
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TURG POIN | Consigliere Generale | 01/06/2018 | - |
Storia della carriera di Naresh K. Nayyar
Precedenti posizioni note di Naresh K. Nayyar
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/04/2016 | 01/05/2018 |
Formazione di Naresh K. Nayyar
| University of Delhi | Doctorate Degree |
| University of Phoenix | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| India | 2 |
Posizioni
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Naresh K. Nayyar
- Esperienza
